BRAF V600E potentially determines “Oncological Resectability” for “Technically Resectable” colorectal liver metastases

BRAF V600E potentially determines “Oncological Resectability” for “Technically Resectable” colorectal liver metastases

Abstract Despite reports on poor survival outcomes after hepatectomy for colorectal liver metastases (CRLM) with BRAF V600E mutation (mBRAF) exist, the role of mBRAF testing for technically resectable cases remains unclear. A single‐center retrospective study was performed to investigate the surviva...

Full description

Bibliographic Details
Main Authors: Shin Kobayashi, Shinichiro Takahashi, Shogo Nomura, Motohiro Kojima, Masashi Kudo, Motokazu Sugimoto, Masaru Konishi, Naoto Gotohda, Hiroya Taniguchi, Takayuki Yoshino
Format: Article
Language:English
Published: Wiley 2021-10-01
Series:Cancer Medicine
Subjects:
BRAF V600E
colorectal liver metastases
hepatectomy
resectable
surgery
Online Access:https://doi.org/10.1002/cam4.4227

Internet

https://doi.org/10.1002/cam4.4227

Similar Items